International normalized ratio (INR) =< .
International normalized ratio (INR) =< .
ELIGIBILITY CRITERIA FOR RANDOMIZATION (STEP ): International normalized ratio (INR) =<  (to be done/tested only for subjects on warfarin)
International normalized ratio (INR) =< .
International normalized ratio (INR) =< .
Obtained within  days prior to treatment start: International normalized ratio (INR) =< .
International normalized ratio (INR) < . x institutional upper limit of normal
International normalized ratio (INR) =< . X upper limit of normal (ULN)
International normalized ratio (INR) =< .
International normalized ratio (INR) =< .
International normalized ratio (INR) =< .
International normalized ratio of < .
International normalized ratio (INR)/PTT =<  times normal; timeline: within  weeks prior to enrollment
International normalized ratio (INR) ? .  ULN (? .  ULN if on anticoagulants)
International normalized ratio (INR) =< .
International normalized ratio (INR) = .
International normalized ratio (INR) =< . unless on direct thrombin inhibitor at time of study entry
International normalized ratio (INR) =< 
International normalized ratio (INR) ?.;
International normalized ratio (INR) =< .
Obtained =<  weeks prior to registration: International normalized ratio (INR) =< . ULN
International normalized ratio =< .
International normalized ratio (INR) =< .
International normalized ratio (INR) ?   ULN
International normalized ratio (INR) =< .
International normalized ratio (INR) =< .
International Normalized Ratio (INR) < . (except if patient is on oral anticoagulation therapy).
Must have an international normalized ratio (INR) < .
International normalized ratio (INR) =< .
International Normalized Ratio (INR) > .
International normalized ratio (INR) < ..
International normalized ratio (INR) =< .
International normalized ratio (INR) < ..
International normalized ratio (INR) less than .  X ULN
International normalized ratio (INR) < ..
International normalized ratio (INR) < .
International normalized ratio (INR) < .
International normalized ratio > .
Patients who have an international normalized ratio (INR) or platelet count which are not correctable to < . and > , respectively
Obtained with  days of registration: international normalized ratio =< .
International normalized ratio (INR) from . to .
International normalized ratio (INR) =< . (except for patients who are on full-dose warfarin)
International normalized ratio (INR) < .
(For both cohorts A and B): International normalized ratio (INR) =< 
International normalized ratio (INR) =< . obtained <  weeks prior to starting treatment
International normalized ratio (INR) =< .
International Normalized Ratio (INR) =< .
International normalized ratio (INR) =< . x ULN
International normalized ratio (INR) =< . x ULN
International normalized ratio (INR) =< .
International normalized ratio (INR) =< .
Obtained within  days prior to registration; international normalized ratio (INR) ? 
Completed within  days of surgery: International normalized ratio INR ? . in patients not utilizing systemic anticoagulation as part of their medical regimen
International normalized ratio (INR) =< . or correctable to . with vitamin K therapy
International normalized ratio (INR) > . INR
International normalized ratio (INR) =< .
International normalized ratio (INR) < . x ULN
International normalized ratio (INR) >= .
Obtained =<  days prior to registration: International normalized ratio (INR) =< .
International normalized ratio (INR) < .
International normalized ratio (INR) < .
International normalized ratio (INR) =< 
International normalized ratio (INR) =< . unless on warfarin in which case INR < . is acceptable
International normalized ration (INR) =< .
International normalized ratio (INR) =< 
International normalized ratio (INR) =< .
International normalized ratio (INR) =< . x institutional ULN
International normalized ratio (INR) is =< .
International normalized ratio (INR) =< 
International normalized ratio (INR) =< 
International normalized ratio (INR) from . to .
Coagulopathy international normalized ratio (INR) > .
Known, existing uncontrolled coagulopathy, international normalized ratio (INR) > .
International normalized ratio (INR) =< .
Known coagulopathy/thrombocytopenia (international normalized ratio [INR] > ., platelets < )
International normalized ratio (INR) < .
International normalized ratio or INR must be =< . unless on therapeutic blood thinners
International normalized ratio (INR) < .
International normalized ratio or INR must be =< .
International normalized ratio (INR) =< .
International normalized ratio (INR) =< 
International normalized ratio (INR) < . x ULN
International normalized ratio (INR) value greater than .
International normalized ratio (INR) =< 
International normalized ratio (INR) < .
International normalized ratio (INR) =< .
International normalized ratio (INR) =< .
International normalized ratio (INR) < 
International normalized ratio or INR must be =< . unless on therapeutic blood thinners
International normalized ratio (INR) < ; subjects on anticoagulant (such as coumadin) must have an international normalized ratio (INR) < 
International normalized ratio (INR) < .
International normalized ratio (INR) must be =< .
International normalized ratio (INR) =< .
International normalized ratio (INR) < . (or <  if on warfarin or other anticoagulants) during screening evaluation
International normalized ratio (INR) > .
International normalized ratio (INR) =< 
International normalized ratio (INR) =< . x upper limit of normal (ULN)
International normalized ration (INR) < .
International normalized ratio (INR) ?  (If coagulopathy is related to disease, this criterion does not apply) within  days prior to registration
International normalized ratio (INR) =< . =<  days prior to registration
International normalized ratio or INR must be ? . unless on therapeutic blood thinners ?  weeks
International normalized ratio (INR) =< .
International normalized ratio (INR) =< .
International normalized ratio (INR) =< .
Within  days prior to registration: International normalized ratio (INR) < .
International normalized ratio (INR) =< .
ARM A: obtained =<  days prior to registration: \r\n* International normalized ratio (INR) =< . x ULN
International normalized ratio (INR) =< . unless receiving therapeutic doses of coumadin
International normalized ratio (INR) =< 
International normalization ratio (INR) =< . mg/dL
International normalized ratio (INR) =< .
International normalized ratio (INR) < . (or <  if on warfarin or other anticoagulants)
International normalized ratio (INR) =< .
International normalized ratio (INR) =< .
Within  days of subject registration: International normalized ratio (INR) =< .
International normalized ratio =< . (or =<  on anticoagulants)
International normalized ratio (INR) =< .
International normalized ratio (INR) =< .
International normalized ratio (INR) =< . X ULN (if not on anticoagulation)
International normalized ratio (INR) < . (or <  if on warfarin or other anticoagulants)
International normalized ratio (INR) =< .
International normalized ratio or INR must be < .
International normalized ratio (INR) =< . x ULN
International normalized ratio (INR) =< 
International normalized ratio (INR) =< . x institutional ULN
International normalized ratio (INR) =< .
International normalized ratio (INR) =< .
Performed within  days of patient registration: International normalized ration (INR) =< .
International normalized ratio (INR) =< , obtained =<  days prior to registration
International normalized ratio (INR) =< .
International normalized ratio (INR) > 
International normalized ratio (INR) > .
International normalized ratio (INR) within normal limits (UIHC)
International normalized ratio (INR) < . x institutional ULN
International normalized ratio (INR) must be < .
International normalized ratio (INR) =< . x ULN
International normalized ratio (INR) =< .
International normalized ratio (INR) =< ; factor A drawn if patient on anticoagulant Eliquis
International normalized ratio (INR) >  in the absence of anticoagulation therapy
International normalized ratio (INR) =< . x ULN
International normalized ratio (INR) =< ..
International normalized ratio (INR) > 
International normalized ratio (INR) =< .
International normalized ratio > .
International normalized ratio (INR) < . times ULN
International normalized ratio (INR) < .
International normalized ratio (INR) =< .
international normalized ratio (INR) must be within normal limits of the local laboratory ranges.
International normalized ratio (INR) =< 
International normalized ratio (INR) < 
International normalized ratio (INR) =< 
International normalized ratio (INR) less than or equal to 
Adequate blood clotting time with an international normalized ratio (INR) < 
International normalized ratio (INR) =< .
International normalized ratio (INR) > 
International Normalized Ratio (INR) less than . within  weeks prior to initial cryoablation procedure.
International normalized ratio (INR) must be less than . in patients not on Coumadin therapy
International normalized ratio (INR) < . (or <  on anticoagulants)
International normalized ratio (INR) must be =< . unless on therapeutic blood thinners
International normalized ratio (INR) =< . (unless due to therapeutic warfarin use)
International normalized ratio or INR must be =< . unless on therapeutic blood thinners
International normalized ratio (INR) =< .
International normalized ratio (INR) < . x ULN
International normalized ratio (INR) =< .
Obtained within  weeks from study entry: International normalized ratio (INR) =< 
International normalized ratio (INR) >= .
International normalized ratio (INR) =< .
International normalized ratio (INR) =< .
International normalized ratio (INR) > .; (in patients receiving anticoagulants [such as warfarin] INR must be between . and . in two consecutive measurements - days apart)
Elevated international normalized ratio (INR) (> .)
International normalized ratio (INR) =< .
International normalized ratio (INR) =< . x ULN
International normalized ratio (INR) =< 
International normalized ratio (INR) =< . (if not due to anticoagulants)
International normalized ratio (INR) =< . x ULN at the time of registration
Platelet count <,/mm or international normalized ratio >..
International normalized ratio (INR) =< 
International normalized ratio (INR) =< 
International normalized ratio (INR) ? . x ULN
International normalized ratio (INR) ? . x ULN
International normalized ratio (INR) < .
International normalized ratio or INR must be =< .
Ongoing treatment with warfarin unless the international normalized ratio (INR) is well controlled and below 
Patients must be appropriate candidates for RFA, with an international normalized ratio of .
International normalized ratio (INR) =< .
For patients not receiving anticoagulation: international normalized ratio of a measure of prothrombin time (international normalized ratio [INR]) =< .
International Normalized Ratio (INR) < . and aPTT within . x ULN
International normalized ratio (INR) < .
International normalized ratio (INR) >.x ULN
International normalized ratio (INR) greater than .
International Normalized Ratio (INR) ?.
An abnormal INR (international normalized ratio of greater than .), if repeatable and refractory to correction by routine methods
International normalized ratio (INR) >= .
International normalized ratio (INR) </=. times ULN
International normalized ratio (INR) < . or patient off Coumadin at the time of ablation
International normalized ratio (INR) < .; if on anticoagulation: INR is required to be between  and 
Known coagulopathy (international normalized ratio [INR] > ., platelets <  K)
International normalized ratio (INR) < .  ULN
International normalized ratio (INR) > . and/or
International normalized ratio (INR) less than or equal to (?) . (unless receiving anticoagulation therapy)
International normalized ratio (INR) =< 
International normalized ratio (INR) < . (or ? . if on therapeutic anticoagulation)
International normalized ratio (INR) < . (or <  on anticoagulants)
International normalized ratio (INR) =< . or
International normalized ratio (INR) =< . X upper limit of normal (ULN)
International normalized ratio (INR) =< . (or =<  on anticoagulants)
International normalized ratio (INR) < .
International normalized ratio (INR) =< .
International normalized ratio (INR) =< .
International normalized ratio (INR) =< .
International normalized ratio (INR) > 
Within  days of surgery: International normalized ratio (INR) =< .
Patients with history of severe liver disease, defined as and confirmed by international normalized ratio (INR) . or greater per institutional laboratory.
International normalized ratio (INR) < . (or <  if on anticoagulant therapy).
International normalized ratio (INR) =< . (corrected if needed)
Currently on warfarin with an international normalized ratio (INR) > . or clopidogrel that cannot be discontinued  days prior to surgery
International normalized ratio (INR) > .
International normalized ratio (INR) =< . times institutional upper limit of normal
Coagulopathy (international normalized ratio [INR] > , platelets < ,)
Obtained =<  days prior to randomization: International normalized ratio (INR) =< . (if not taking anticoagulant therapy)
International normalized ratio (INR) =< .
Patients with international normalized ratio (INR) > .
International normalized ratio (INR) =< 
Minocycline trial only: patients who are under treatment of warfarin with international normalized ratio (INR) > .
INR (International Normalized Ratio) <. within  weeks screening
International normalized ratio (INR) =< . (within  days of surgery)
International normalized ratio (INR) =< .
International normalized ratio (INR) =< 
International normalized ratio (INR) =< 
International normalized ratio (INR) =< . x ULN
International normalized ratio (INR) =< .
International normalized ratio (INR) < . \r\n* For patients on Coumadin general clinical guidelines for interventional radiology (IR) ablation will be followed
Coagulopathy with international normalized ratio (INR) > . or
Severe coagulopathy (international normalized ratio [INR] > .) or
Low-density lipoprotein (LDL) question for lung surgery do we need an international normalized ratio (INR) < .
International normalized ratio (INR) < . (or <  if on warfarin or other anticoagulants) at the screening visit
International Normalized Ratio (INR) < . (except if patient is on oral anticoagulation therapy).
International Normalized Ratio (INR) >. x ULN